Akoya Biosciences, Inc.

NASDAQ:AKYA

3.19 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -63.323-70.641-42.935-16.706-14.751
Depreciation & Amortization 8.897.1494.7923.8153.055
Deferred Income Tax -0.0510.035-0.1550.0070.156
Stock Based Compensation 10.4377.434.0390.4770.153
Change In Working Capital -12.0582.164-4.5612.394-1.377
Accounts Receivables -7.265-0.285-2.9746.697-3.373
Inventory -6.332-5.374-4.628-0.684-4.007
Accounts Payables 1.1481.1934.361-3.045-0.049
Other Working Capital 0.3916.63-1.32-0.5746.052
Other Non Cash Items 5.2060.3672.7523.17-1.012
Operating Cash Flow -50.899-53.496-36.068-6.843-13.776
Investing Activities:
Investments In Property Plant And Equipment -3.653-7.36-5.094-3.295-2.869
Acquisitions Net 00.05500.1450
Purchases Of Investments 0-40.7740-0.145-10
Sales Maturities Of Investments 734010.1680
Other Investing Activites 7-6.7190-0.145-0.023
Investing Cash Flow 3.347-14.079-5.0946.728-12.892
Financing Activities:
Debt Repayment 00000
Common Stock Issued 48.3130.447138.9470.12224.828
Common Stock Repurchased -0.0940000
Dividends Paid 00-1.43500
Other Financing Activities 19.07228.9137.35730.55528.774
Financing Cash Flow 56.84428.726137.0355.48628.561
Other Information:
Effect Of Forex Changes On Cash -0.3960000
Net Change In Cash 8.896-38.84995.8735.3711.893
Cash At End Of Period 83.12574.532113.38117.50812.137